Abstract: An indoor and outdoor ventilation device includes a fan, an air inlet casing, and an exhaust window. The fan is installed on an indoor side. The air inlet casing and the exhaust window installed on an outdoor side. An air inlet and an air outlet are arranged on the air inlet casing. The fan is communicated with the air outlet. A filter net and an air filter are sequentially installed in the air inlet casing from the air inlet to the air outlet. The exhaust window is mounted on a wall body for communication with indoor air and outside air.

Abstract: An air purification device includes a case divided into first and second chambers, a filter unit disposed in the first chamber, and a negative pressure generator disposed in the second chamber. The filter unit comprises an outer frame, a filter screen disposed in the outer frame, and a dust removing device including a dust removing assembly, a first driving mechanism and a second driving mechanism. A peripheral edge of the filter screen is connected to an inner side of the outer frame. The dust removing assembly is movably mounted on the outer frame for removing dust from the filter screen. The first driving mechanism drives the dust removing assembly to move back and forth in a width direction of the filter screen, and the second driving mechanism drives the dust removing assembly to move back and forth in a length direction of the filter screen.

Abstract: Provided is a no-liquid cell-core for a lithium slurry battery. The no-liquid cell-core comprises multiple positive electrode pieces and negative electrode pieces overlapping alternately. The positive electrode piece comprises an electric-conductive cathode layer and a cathode surface current-collecting layer, wherein the electric-conductive cathode layer contains a part or all of the electric-conductive cathode particles in accumulated state without adhesive bonding, and the cathode surface current-collecting layer is set on the surface of the electric-conductive cathode layer and contacted with it tightly. The negative electrode piece comprises an electric-conductive lithium-intercalatable anode layer which is a lithium-containing metal body and/or a layer containing a part or all of electric-conductive lithium-intercalatable anode particles in accumulated state without adhesive bonding. The peripheral edges of the positive electrode piece and/or the negative electrode piece are insulated and sealed.

Abstract: The present disclosure provides heteroaryl compounds of formulas I, Ia and Ib, processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis.

Abstract: Systems and methods are disclosed to control a power inverter by extracting photovoltaic (PV) maximum power under a plurality of operating conditions as one or more reference variables; predicting the future behaviors of a PV output voltage as one or more controlled variables based on a current operational condition; generating one or more control signals for the H5 inverter that minimizes an error between the reference variable and the controlled variables; and controlling the power inverter with the one or more control signals.

Abstract: The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to the CXCR4 pathway.

Abstract: Systems and methods are disclosed to control voltage profiles of a power grid by forming an autonomous voltage control model with one or more neural networks as Deep Reinforcement Learning (DRL) agents; training the DRL agents to provide data-driven, real-time and autonomous grid control strategies; and coordinating and optimizing reactive power controllers to regulate voltage profiles in the power grid with a Markov decision process (MDP) operating with reinforcement learning to control problems in dynamic and stochastic environments.

Abstract: Disclosed are compositions and methods for the electrochemical detection of enzymes, such as enzymes that are indicative of disease, disorders, or pathogens, such as viruses, bacteria, and fungi, or other disorders. These methods can be used in point-of-care diagnostic assays for the detection of disease, disorder, or pathogen (e.g., to identify the strain of pathogen infecting a patient in a healthcare setting). The electrochemical methods described herein can also be used to assess the susceptibility of a pathogen to an antipathogen drug. Also provided are probes suitable for use in conjunction with the methods described herein.

Abstract: Inhibitors of Wnt signaling pathway with structures of Formula I are disclosed, together with their pharmaceutical salts. Applications of compounds of Formula I in inhibiting or modulating the Wnt signaling pathway are also disclosed. Compounds of Formula I can treat disorders caused by aberrant activation of the Wnt signaling pathway.

Abstract: Systems and methods are disclosed to control a power inverter by extracting photovoltaic (PV) maximum power under a plurality of operating conditions as one or more reference variables; predicting the future behaviors of a PV output voltage as one or more controlled variables based on a current operational condition; generating one or more control signals for the H5 inverter that minimizes an error between the reference variable and the controlled variables; and controlling the power inverter with the one or more control signals.

Abstract: Inhibitors of Wnt signaling pathway with structures of Formula I are disclosed, together with their pharmaceutical salts. Applications of compounds of Formula I in inhibiting or modulating the Wnt signaling pathway are also disclosed. Compounds of Formula I can treat disorders caused by aberrant activation of the Wnt signaling pathway.

Abstract: The present disclosure provides heteroaryl compounds of formulas I, Ia and Ib, processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis.

Abstract: Disclosed are compositions and methods for the electrochemical detection of enzymes, such as enzymes that are indicative of disease, disorders, or pathogens, such as viruses, bacteria, and fungi, or other disorders. These methods can be used in point-of-care diagnostic assays for the detection of disease, disorder, or pathogen (e.g., to identify the strain of pathogen infecting a patient in a healthcare setting). The electrochemical methods described herein can also be used to assess the susceptibility of a pathogen to an antipathogen drug. Also provided are probes suitable for use in conjunction with the methods described herein.

Abstract: A chiral heterocyclic compound with hedgehog pathway antagonist activity, method and use thereof are provided. The chiral heterocyclic compound with hedgehog pathway antagonist activity has the structure represented by formula I. A pharmaceutical composition and combined application composition are also provided. Novel molecules of formula II that inhibit hedgehog pathway signaling and therapeutic applications for the treatment of malignancies, prevention of tumor regrowth, sensitization of radio-chemo therapies, and other diseases related to hedgehog signaling are also provided.

Abstract: Systems and method are disclosed for monitor long-term voltage stability in a power system by estimating post-contingency operating point(s) considering PV-PQ transitions based on the current operating point; predicting a sensitivity based Thevenin index (STI) for each contingency using the estimated operating condition; and determining a voltage stability assessment (VSA) considering N?1 contingency.

Abstract: Provided is a no-liquid cell-core for a lithium slurry battery. The no-liquid cell-core comprises multiple positive electrode pieces and negative electrode pieces overlapping alternately. The positive electrode piece comprises an electric-conductive cathode layer and a cathode surface current-collecting layer, wherein the electric-conductive cathode layer contains a part or all of the electric-conductive cathode particles in accumulated state without adhesive bonding, and the cathode surface current-collecting layer is set on the surface of the electric-conductive cathode layer and contacted with it tightly. The negative electrode piece comprises an electric-conductive lithium-intercalatable anode layer which is a lithium-containing metal body and/or a layer containing a part or all of electric-conductive lithium-intercalatable anode particles in accumulated state without adhesive bonding. The peripheral edges of the positive electrode piece and/or the negative electrode piece are insulated and sealed.

Abstract: Inhibitors of Wnt signaling pathway with structures of Formula I are disclosed, together with their pharmaceutical salts. Applications of compounds of Formula I in inhibiting or modulating the Wnt signaling pathway are also disclosed. Compounds of Formula I can treat disorders caused by aberrant activation of the Wnt signaling pathway.

Abstract: Methods, systems, and devices for wireless communication are described. A user equipment (UE) may perform uplink communications on a first radio frequency spectrum band using a first transceiver and a first antenna. The first transceiver may have a first capability configuration. The UE may receive an assignment for uplink communications on a second radio frequency spectrum band and couple a second transceiver to the first antenna to perform the uplink communications on the first radio frequency spectrum band. The spectrum transceiver may have a second capability configuration that is different from the first capability configuration with respect to at least the second radio frequency spectrum band. The UE may switch the first transceiver to a second antenna for the uplink communications on the second radio frequency spectrum band.

Abstract: Diamino-pyridine, pyrimidine and pyridazine compounds which may be used as H4 receptor modulators, and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.

Abstract: Diamino-pyridine, pyrimidine and pyridazine compounds which may be used as H4 receptor modulators, and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.